跳至主要内容
临床试验/JPRN-UMIN000006453
JPRN-UMIN000006453招募中2 期

Assessment of the Efficacy of Preoperative Exemestane Therapy for Endocrine-sensitive Postmenopausal Breast Cancer (SBCCSG-23) - Assessment of the Efficacy of Preoperative Exemestane Therapy for Endocrine-sensitive Postmenopausal Breast Cancer (SBCCSG-23)

PO Saitama Breast Cancer Clinical Study Group (SBCCSG)0 个研究点目标入组 60 人开始时间: 2011年10月3日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Exclusion criteria (1)Patients already receiving breast cancer treatment either with chemotherapy or endocrine therapy; (2)Patients who have a history of breast cancer. However, a patient can be considered eligible if the patient has metachronous bilateral breast cancer and it has been 10 years or more since the patient underwent surgery for contralateral breast cancer; (3)Patients who have active multiple primary cancer; (4)Patients who should receive surgery, chemotherapy or molecular targeted therapy instead of endocrine therapy as first line treatment; (5)Besides the above, patients that are considered ineligible by the principal investigator.

研究者

发起方
PO Saitama Breast Cancer Clinical Study Group (SBCCSG)

相似试验